PortfoliosLab logo
Hologic, Inc. (HOLX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US4364401012

CUSIP

436440101

IPO Date

Jun 21, 1990

Highlights

Market Cap

$13.14B

EPS (TTM)

$3.16

PE Ratio

18.42

PEG Ratio

1.27

Total Revenue (TTM)

$3.02B

Gross Profit (TTM)

$1.70B

EBITDA (TTM)

$1.03B

Year Range

$55.89 - $84.67

Target Price

$75.40

Short %

3.93%

Short Ratio

1.93

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Hologic, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


1,500.00%2,000.00%2,500.00%December2025FebruaryMarchAprilMay
1,870.89%
1,454.68%
HOLX (Hologic, Inc.)
Benchmark (^GSPC)

Returns By Period

Hologic, Inc. (HOLX) returned -20.54% year-to-date (YTD) and -24.91% over the past 12 months. Over the past 10 years, HOLX returned 5.25% annually, underperforming the S&P 500 benchmark at 10.26%.


HOLX

YTD

-20.54%

1M

-6.68%

6M

-29.17%

1Y

-24.91%

5Y*

3.01%

10Y*

5.25%

^GSPC (Benchmark)

YTD

-4.72%

1M

-0.51%

6M

-1.78%

1Y

11.67%

5Y*

14.69%

10Y*

10.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of HOLX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20250.07%-12.13%-2.56%-5.78%-1.58%-20.54%
20244.18%-0.86%5.64%-2.81%-2.63%0.64%9.91%-0.45%0.27%-0.72%-1.69%-9.32%0.90%
20238.77%-2.13%1.33%6.58%-8.28%2.64%-1.91%-5.89%-7.14%-4.65%7.75%0.21%-4.49%
2022-8.25%1.32%7.94%-6.29%4.56%-7.93%3.00%-5.35%-4.50%5.08%12.33%-1.77%-2.29%
20219.47%-9.58%3.18%-11.87%-3.80%5.80%12.47%5.48%-6.75%-0.68%1.94%2.45%5.12%
20202.51%-11.96%-25.51%42.74%5.79%7.55%22.42%-14.42%11.30%3.54%0.45%5.35%39.49%
20198.03%6.19%2.65%-4.17%-5.11%9.11%6.73%-3.67%2.27%-4.32%6.23%1.73%27.03%
2018-0.12%-9.06%-3.79%3.83%-2.32%4.91%7.95%-7.34%3.07%-4.86%13.90%-7.45%-3.86%
20171.02%0.12%4.85%6.11%-4.08%4.78%-2.58%-12.69%-4.95%3.16%10.22%2.47%6.56%
2016-12.28%2.03%-0.38%-2.64%2.44%0.55%11.24%-0.18%1.07%-7.26%6.30%4.81%3.70%
201513.56%6.64%1.99%2.17%6.02%6.40%9.46%-6.84%0.82%-0.69%3.83%-4.11%44.69%
2014-4.43%1.97%-1.29%-2.40%16.46%3.72%2.84%-4.60%-2.17%7.64%2.33%-0.22%19.64%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of HOLX is 5, meaning it’s performing worse than 95% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of HOLX is 55
Overall Rank
The Sharpe Ratio Rank of HOLX is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of HOLX is 66
Sortino Ratio Rank
The Omega Ratio Rank of HOLX is 77
Omega Ratio Rank
The Calmar Ratio Rank of HOLX is 99
Calmar Ratio Rank
The Martin Ratio Rank of HOLX is 33
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Hologic, Inc. (HOLX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for HOLX, currently valued at -1.15, compared to the broader market-2.00-1.000.001.002.003.00
HOLX: -1.15
^GSPC: 0.49
The chart of Sortino ratio for HOLX, currently valued at -1.47, compared to the broader market-6.00-4.00-2.000.002.004.00
HOLX: -1.47
^GSPC: 0.81
The chart of Omega ratio for HOLX, currently valued at 0.80, compared to the broader market0.501.001.502.00
HOLX: 0.80
^GSPC: 1.12
The chart of Calmar ratio for HOLX, currently valued at -0.71, compared to the broader market0.001.002.003.004.005.00
HOLX: -0.71
^GSPC: 0.50
The chart of Martin ratio for HOLX, currently valued at -1.75, compared to the broader market-10.000.0010.0020.00
HOLX: -1.75
^GSPC: 2.00

The current Hologic, Inc. Sharpe ratio is -1.15. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Hologic, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
-1.15
0.49
HOLX (Hologic, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Hologic, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-34.66%
-8.79%
HOLX (Hologic, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Hologic, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Hologic, Inc. was 93.75%, occurring on Oct 21, 1999. Recovery took 1478 trading sessions.

The current Hologic, Inc. drawdown is 34.66%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.75%Jun 26, 1996839Oct 21, 19991478Sep 8, 20052317
-87.61%Jul 17, 1990862Dec 15, 1993480Nov 8, 19951342
-73.65%Dec 27, 2007301Mar 9, 20091567May 29, 20151868
-46.24%Jan 30, 202037Mar 23, 202062Jun 19, 202099
-35.83%Apr 3, 200649Jun 12, 2006160Jan 31, 2007209

Volatility

Volatility Chart

The current Hologic, Inc. volatility is 8.47%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%December2025FebruaryMarchAprilMay
8.47%
14.11%
HOLX (Hologic, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Hologic, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Hologic, Inc., comparing actual results with analytics estimates. The company met analyst expectations for EPS in the past quarter.

0.501.001.502.002.503.00AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
1.03
1.02
Actual
Estimate

Valuation

The Valuation section provides an overview of how Hologic, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
HOLX: 18.4
The chart displays the Price-to-Earnings (P/E) ratio for HOLX, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, HOLX has a P/E ratio of 18.4. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
2.04.06.08.010.0
HOLX: 1.3
The chart shows the Price/Earnings to Growth (PEG) ratio for HOLX compared to other companies in the Medical Instruments & Supplies industry. HOLX currently has a PEG ratio of 1.3. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
2.04.06.08.010.0
HOLX: 3.3
This chart shows the Price-to-Sales (P/S) ratio for HOLX relative to other companies in the Medical Instruments & Supplies industry. Currently, HOLX has a P/S ratio of 3.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
2.04.06.08.010.0
HOLX: 2.7
The chart illustrates the Price-to-Book (P/B) ratio for HOLX in comparison with other companies in the Medical Instruments & Supplies industry. Currently, HOLX has a P/B value of 2.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items